In the next experiments, we assessed the protein biomarker of sEV with FITC-conjugated mAbs specific to CD63 and CD9 derived from fresh liver cancer tissue, frozen liver cancer tissue and cultured liver cancer tissue sections. This evidence concerns the gene CD9 and liver cancer.